The 2019 report from the European Monitoring Centre for Drugs and Drug Addiction has been released. This report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy and responses.
More than 9 000 lives were reported to be lost to drug overdoses in Europe (28 EU Member States, Turkey and Norway) in 2016, the latest reporting year, and this is an underestimate. Reducing drug-related deaths therefore remains a major challenge for public health policy. This analysis describes some of the factors that increase the risk of fatal and non-fatal overdoses and a number of interventions developed to prevent these events. Part of the ‘Perspectives on drugs’ (PODs) series, launched alongside the annual European Drug Report, these designed-for-the-web interactive analyses aim to provide deeper insights into a selection of important issues.
The 2018 report from the European Monitoring Centre for Drugs and Drug Addiction has been released, this report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy and responses.
Since the beginning of the National Naloxone Programme, the Scottish Government has commissioned Information Services Division (ISD) to report on THN kit distribution using monitoring data supplied by NHS Boards. This report presents information on the number of THN kits issued from 2011/12 to 2017/18. Data are presented separately for kits issued from community outlets, kits issued in prisons at the point of prisoner release and kits dispensed via community prescription. The number and percentage of opioid-related deaths that occurred within four or twelve weeks of prison release or hospital discharge are also presented.
